Ferumoxytol: A guide to its use in iron deficiency anaemia in adults with chronic kidney disease in the EU

被引：1

作者：

Scott L.J. ^{[1
]}

Lyseng-Williamson K.A. ^{[1
]}

McCormack P.L. ^{[1
]}

机构：

[1] Adis 41, 0754 Auckland, Centorian Drive, Mairangi Bay, North Shore

来源：

Drugs & Therapy Perspectives | 2013年 / 29卷 / 8期

关键词：

Chronic Kidney Disease; Chronic Kidney Disease Patient; Iron Deficiency Anaemia; Serum Ferritin Level; Darbepoetin Alfa;

D O I：

10.1007/s40267-013-0055-7

中图分类号：

学科分类号：

摘要：

Ferumoxytol, a high-molecular-weight carbohydrate-iron complex, is indicated for the intravenous treatment of iron deficiency anaemia in adults with chronic kidney disease. In this population, a repletion course of intravenous ferumoxytol is significantly more effective than a short course of oral iron in increasing haemoglobin levels and improving most other iron indices, irrespective of whether patients are on haemodialysis or not on dialysis, and is generally well tolerated. © 2013 Springer International Publishing Switzerland.

引用

页码：223 / 227

页数：4